Increased plasma oxidizability in subjects with severe obesity

Journal of Nutritional and Environmental Medicine

Volumn 6, Issue 3, 1996, Pages 267-272

  Pipek, Ruben ^a   Dankner, Gertrude ^a   Ben Amotz, Ami ^b   Aviram, Michael ^a   Levy, Yishai ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b ISRAEL OCEANOGRAPHIC AND LIMNOLOGICAL RESEARCH   (Israel)

Author keywords

Antioxidant vitamins; Hyperinsulinaemia; Lipid peroxidation; Obesity

Indexed keywords

ALKADIENE; ANTIOXIDANT; CAROTENOID; FREE RADICAL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; VITAMIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; LIPID PEROXIDATION; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0029868753     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.3109/13590849609007253     Document Type: Article

References (27)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease; a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-72.
2. Aviram M. Modified forms of low density lipoprotein and atherogenesis. Atherosclerosis 1993; 98: 1-9.
3. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-92.
4. Esterbauer H, Rotheneder M, Striegl G et al. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Tech 1989; 91: 316-24.
5. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991; 53: 314s-321s.
6. Gey KF, Puska P, Jordan P. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53: 326-48.
7. Rimm EB, Stampfer MJ, Ascherio A. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6.
8. Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Int Med 1993; 234: 53-60.
9. Lapel D, Donell HM. Abnormal antioxidant defense in some tissues of congenitally obese mice. Biochem J 1984; 219: 41-9.
10. Tozzi E, Tozzi-Ciancarelli MG, DiMassimo C. Hemorheological parameters and body weight loss in obese children. Clin Hemorheol 1994; 14: 203-11.
11. Ohrvall M, Tengblad S, Ekstrand B et al. Malondialdehyde concentration in plasma is inversely correlated to the proportion of lineolic acid in serum lipoprotein lipids. Atherosclerosis 1994; 108: 103-10.
12. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.
13. El Saadani M, Esterbauer H, El Sayad M et al. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30: 627-31.
14. Levy Y, Ben-Amotz A, Aviram M. Effect of dietary supplementation of different β-carotene isomers on lipoprotein oxidative modification. J Nutr Med 1995; 5: 13-22.
15. Hayek T, Oiknine J, Brook JG, Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun 1994; 201: 1567-74.
16. Arshad MAP, Bhadra S, Cohen RM, Subbiah MT. Plasma lipid peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin Chem 1991; 37: 1756-8.
17. Frei B, Stocker R, Ames B. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748-52.
18. Halliwel B. Albumin - an important extracellular antioxidant? Biochem Pharmocol 1988; 37: 569-71.
19. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
20. Polansky KS, Given BD, Hirsh LJ et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988; 81: 435-41.
21. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanics of insulin in human obesity: evidence for receptor and post receptor defects. J Clin Invest 1980; 65: 1272-84.
22. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
23. Haffner SM, Agil A, Mykkanen L et al. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995; 18: 646-53.
24. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study. Ann Intern Med 1979; 90: 85-91.
25. Denke MA, Tempos CT, Grundy SM. Excess body weight: a recognized contributer to high blood cholesterol levels in white American men. Arch Int Med 1993; 153: 1093-103.
26. Levy Y, Ben-Amotz A, Dankner G et al. Enhanced lipid peroxidation of low density lipoprotein with fish oil. J Optimal Nutr 1993; 2: 6-9.
27. Rock CL, Swendseid M. Plasma carotenoid levels in anorexia nervosa and in obese patients. Methods Enzymol 1993; 214: 116-23.